BR1017-1

DRUG2 trials

Sponsors

Boryung Pharmaceutical Co., Ltd

Conditions

Essential HypertensionHypercholesterinemiaHypertensionPrimary Hypercholesterolemia

Phase 1

A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers

CompletedNCT05372380

Boryung Pharmaceutical Co., LtdHypercholesterinemia, Hypertension

Start: 2022-05-09End: 2022-06-30Updated: 2023-02-08

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1017-1 and Co-administration of BR1017-1A and BR1017-1B

CompletedNCT06184269

Boryung Pharmaceutical Co., LtdEssential Hypertension, Primary Hypercholesterolemia

Start: 2023-12-23End: 2024-02-18Updated: 2024-04-02